CytomX醫療 CTMX 深 滬
已收盤 05-08 16:00:00 美东时间
3.98
-0.020
-0.50%
華盛通- 最 高4.23
- 今 開4.04
- 成交量 505.50万股
- 最 低 3.855
- 昨 收 4.00
- 總市值 8.66亿
- 52周最高 8.21
- 市盈率 靜 --
- 換手率 2.32%
- 52周最低 1.72
- 委 比 -35.32%
- 總股本 2.18亿
- 歷史最高 35.00
- 量 比 1.86
- 振 幅 9.38%
- 歷史最低 0.40
- 每 手 1
- 風險率 1.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CytomX Therapeutics Q1 EPS $(0.10) Beats $(0.20) Estimate, Sales $10.258M Beat $4.713M Estimate
CytomX Therapeutics (NASDAQ:CTMX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.20) by 50 percent. This is a 137.04 percent decrease over earnings of $0.27 per share from
05-08 04:19
Penny Stock Oncolytics Biotech Says Colorecatal Cancer Drug's Durability Tops Historical Benchmarks
Oncolytics shares rise as pelareorep shows 19.5-month response durability and higher response rates in colorectal cancer study.
05-05 00:42
美股大行评级 | 瑞穗上调MongoDB至"跑赢大市"，目标价从290美元升至325美元；麦格理下调小鹏评级至"中性" 目标价从24美元降至19美元
今日重点评级关注：HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从12美元升至13美元；Litchfield Hills：维持Star Equity Holdings"买入"评级，目标价从21美元升至28美元
03-24 10:07
Piper Sandler Maintains Overweight on CytomX Therapeutics, Raises Price Target to $12
Piper Sandler analyst Joseph Catanzaro maintains CytomX Therapeutics (NASDAQ:CTMX) with a Overweight and raises the price target from $10 to $12.
03-24 00:51
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
Why Is CytomX Therapeutics Stock Falling On Wednesday?
CytomX stock falls after $250 million share sale, even as new colorectal cancer data shows strong response and growth potential.
03-19 01:06
BUZZ-CytomX drops on $250 mln equity raise
BUZZ-CytomX drops on $250 mln equity raise ** CytomX Therapeutics CTMX.O shares down 3.7% before the bell at $5.25 after $250 mln follow-on priced ** South San Francisco, California-based firm late Tues announced ~47.2 mln shares, including pre-funded warrants to buy ~1.2 mln shares, at $5.30 ** Off
03-18 21:05
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
